RATIONALE: Chromosome 12p has been linked to chronic obstructive pulmonary disease (COPD) in the Boston Early-Onset COPD Study (BEOCOPD), but a susceptibility gene in that region has not been identified. OBJECTIVES: We used high-density single-nucleotide polymorphism (SNP) mapping to implicate a COPD susceptibility gene and an animal model to determine the potential role of SOX5 in lung development and COPD. METHODS: On chromosome 12p, we genotyped 1,387 SNPs in 386 COPD cases from the National Emphysema Treatment Trial and 424 control smokers from the Normative Aging Study. SNPs with significant associations were then tested in the BEOCOPD study and the International COPD Genetics Network. Based on the human results, we assessed histology and gene expression in the lungs of Sox5(-/-) mice. MEASUREMENTS AND MAIN RESULTS: In the case-control analysis, 27 SNPs were significant at P ≤ 0.01. The most significant SNP in the BEOCOPD replication was rs11046966 (National Emphysema Treatment Trial-Normative Aging Study P = 6.0 × 10(-4), BEOCOPD P = 1.5 × 10(-5), combined P = 1.7 × 10(-7)), located 3' to the gene SOX5. Association with rs11046966 was not replicated in the International COPD Genetics Network. Sox5(-/-) mice showed abnormal lung development, with a delay in maturation before the saccular stage, as early as E16.5. Lung pathology in Sox5(-/-) lungs was associated with a decrease in fibronectin expression, an extracellular matrix component critical for branching morphogenesis. CONCLUSIONS: Genetic variation in the transcription factor SOX5 is associated with COPD susceptibility. A mouse model suggests that the effect may be due, in part, to its effects on lung development and/or repair processes.
RCT Entities:
RATIONALE: Chromosome 12p has been linked to chronic obstructive pulmonary disease (COPD) in the Boston Early-Onset COPD Study (BEOCOPD), but a susceptibility gene in that region has not been identified. OBJECTIVES: We used high-density single-nucleotide polymorphism (SNP) mapping to implicate a COPD susceptibility gene and an animal model to determine the potential role of SOX5 in lung development and COPD. METHODS: On chromosome 12p, we genotyped 1,387 SNPs in 386 COPD cases from the National Emphysema Treatment Trial and 424 control smokers from the Normative Aging Study. SNPs with significant associations were then tested in the BEOCOPD study and the International COPD Genetics Network. Based on the human results, we assessed histology and gene expression in the lungs of Sox5(-/-) mice. MEASUREMENTS AND MAIN RESULTS: In the case-control analysis, 27 SNPs were significant at P ≤ 0.01. The most significant SNP in the BEOCOPD replication was rs11046966 (National Emphysema Treatment Trial-Normative Aging Study P = 6.0 × 10(-4), BEOCOPD P = 1.5 × 10(-5), combined P = 1.7 × 10(-7)), located 3' to the gene SOX5. Association with rs11046966 was not replicated in the International COPD Genetics Network. Sox5(-/-) mice showed abnormal lung development, with a delay in maturation before the saccular stage, as early as E16.5. Lung pathology in Sox5(-/-) lungs was associated with a decrease in fibronectin expression, an extracellular matrix component critical for branching morphogenesis. CONCLUSIONS: Genetic variation in the transcription factor SOX5 is associated with COPD susceptibility. A mouse model suggests that the effect may be due, in part, to its effects on lung development and/or repair processes.
Authors: Craig P Hersh; Sreekumar G Pillai; Guohua Zhu; David A Lomas; Per Bakke; Amund Gulsvik; Dawn L DeMeo; Barbara J Klanderman; Ross Lazarus; Augusto A Litonjua; David Sparrow; John J Reilly; Alvar Agusti; Peter M A Calverley; Claudio F Donner; Robert D Levy; Barry J Make; Peter D Paré; Stephen I Rennard; Jørgen Vestbo; Emiel F M Wouters; Mary Beth Scholand; Hilary Coon; John Hoidal; Edwin K Silverman Journal: Am J Respir Crit Care Med Date: 2010-05-12 Impact factor: 21.405
Authors: D E Adkins; K Aberg; J L McClay; J Bukszár; Z Zhao; P Jia; T S Stroup; D Perkins; J P McEvoy; J A Lieberman; P F Sullivan; E J C G van den Oord Journal: Mol Psychiatry Date: 2010-03-02 Impact factor: 15.992
Authors: Juan C Celedón; Christoph Lange; Benjamin A Raby; Augusto A Litonjua; Lyle J Palmer; Dawn L DeMeo; John J Reilly; David J Kwiatkowski; Harold A Chapman; Nan Laird; Jody S Sylvia; Melvin Hernandez; Frank E Speizer; Scott T Weiss; Edwin K Silverman Journal: Hum Mol Genet Date: 2004-06-02 Impact factor: 6.150
Authors: George R Uhl; Qing-Rong Liu; Tomas Drgon; Catherine Johnson; Donna Walther; Jed E Rose; Sean P David; Ray Niaura; Caryn Lerman Journal: Arch Gen Psychiatry Date: 2008-06
Authors: Edwin K Silverman; Jonathan D Mosley; Lyle J Palmer; Matthew Barth; Jody M Senter; Alison Brown; Jeffrey M Drazen; David J Kwiatkowski; Harold A Chapman; Edward J Campbell; Michael A Province; D C Rao; John J Reilly; Leo C Ginns; Frank E Speizer; Scott T Weiss Journal: Hum Mol Genet Date: 2002-03-15 Impact factor: 6.150
Authors: Edwin K Silverman; Lyle J Palmer; Jonathan D Mosley; Matthew Barth; Jody M Senter; Alison Brown; Jeffrey M Drazen; David J Kwiatkowski; Harold A Chapman; Edward J Campbell; Michael A Province; D C Rao; John J Reilly; Leo C Ginns; Frank E Speizer; Scott T Weiss Journal: Am J Hum Genet Date: 2002-03-25 Impact factor: 11.025
Authors: Josiah E Radder; Yingze Zhang; Alyssa D Gregory; Shibing Yu; Neil J Kelly; Joseph K Leader; Naftali Kaminski; Frank C Sciurba; Steven D Shapiro Journal: Am J Respir Crit Care Med Date: 2017-07-15 Impact factor: 21.405
Authors: Koustav Ganguly; Timothy M Martin; Vincent J Concel; Swapna Upadhyay; Kiflai Bein; Kelly A Brant; Leema George; Ankita Mitra; Tania A Thimraj; James P Fabisiak; Louis J Vuga; Cheryl Fattman; Naftali Kaminski; Holger Schulz; George D Leikauf Journal: Am J Respir Cell Mol Biol Date: 2014-11 Impact factor: 6.914
Authors: Megan Hardin; Michael Cho; Merry-Lynn McDonald; Terri Beaty; Joe Ramsdell; Surya Bhatt; Edwin J R van Beek; Barry J Make; James D Crapo; Edwin K Silverman; Craig P Hersh Journal: Eur Respir J Date: 2014-05-29 Impact factor: 16.671
Authors: Airong Li; Osman O Ahsen; Jonathan J Liu; Chuang Du; Mary L McKee; Yan Yang; Wilma Wasco; Christopher H Newton-Cheh; Christopher J O'Donnell; James G Fujimoto; Chao Zhou; Rudolph E Tanzi Journal: Hum Mol Genet Date: 2013-05-21 Impact factor: 6.150
Authors: Benjamin M Smith; Hussein Traboulsi; John H M Austin; Ani Manichaikul; Eric A Hoffman; Eugene R Bleecker; Wellington V Cardoso; Christopher Cooper; David J Couper; Stephen M Dashnaw; Jia Guo; MeiLan K Han; Nadia N Hansel; Emlyn W Hughes; David R Jacobs; Richard E Kanner; Joel D Kaufman; Eric Kleerup; Ching-Long Lin; Kiang Liu; Christian M Lo Cascio; Fernando J Martinez; Jennifer N Nguyen; Martin R Prince; Stephen Rennard; Stephen S Rich; Leora Simon; Yanping Sun; Karol E Watson; Prescott G Woodruff; Carolyn J Baglole; R Graham Barr Journal: Proc Natl Acad Sci U S A Date: 2018-01-16 Impact factor: 11.205